Search research articles
Contact Us
Filters
Showing results (51-60 of 349) with videos related to
Page
of 35
Sort By:
Drug Design, Development and Therapy
|
October 23, 2014
Evaluation of the pharmacokinetic and pharmacodynamic drug interactions between cilnidipine and valsartan, in healthy volunteers
Jieon Lee, Howard Lee, Kyungho Jang, et al.
Translational and Clinical Pharmacology
|
April 15, 2021
Comparative pharmacokinetics between tenofovir disoproxil phosphate and tenofovir disoproxil fumarate in healthy subjects
Sangmi Lee, Eunwoo Kim, Seol Ju Moon, et al.
International Journal of Clinical Pharmacology and Therapeutics
|
December 22, 2018
Pharmacokinetic comparison of gemigliptin 50 mg and metformin 500 mg as a fixed-dose combination and loose combination
Sang Won Lee, Sang-In Park, SeungHwan Lee, et al.
Drug Design, Development and Therapy
|
November 22, 2017
A comparative pharmacokinetic and tolerability analysis of the novel orotic acid salt form of tenofovir disoproxil and the fumaric acid salt form in healthy subjects
Yu Kyong Kim, Mun Ju Choi, Tae Young Oh, et al.
International Journal of Clinical Pharmacology and Therapeutics
|
September 13, 2016
A bioequivalence study of two omeprazole formulations in healthy male volunteers
Yu Kyong Kim, Seonghae Yoon, Kyung-Sang Yu, et al.
Investigational New Drugs
|
January 29, 2014
An assessment of the pharmacokinetics, pharmacodynamics, and tolerability of GCPGC, a novel pegylated granulocyte colony-stimulating factor (G-CSF), in healthy subjects
Kwang-Hee Shin, Kyoung Soo Lim, Howard Lee, et al.
International Journal of Clinical Pharmacology and Therapeutics
|
April 10, 2020
Comparative pharmacokinetics of a montelukast/levocetirizine fixed-dose combination chewable tablet versus individual administration of montelukast and levocetirizine after a single oral administration in healthy Korean male subjects
Seol Ju Moon, Kyung-Sang Yu, Jina Jung, et al.
Drug Design, Development and Therapy
|
September 15, 2025
Population Pharmacokinetic and Pharmacodynamic Modeling of Enteric-Coated Aspirin Capsule and Tablet Formulations in Healthy Subjects
JaeEun Koh, Juyoung Khwarg, Kyung-Sang Yu, et al.
Journal of Clinical Pharmacology
|
April 16, 2026
Population Pharmacokinetic Analysis of MIT-001, a Novel Ferroptosis Inhibitor, for Dose Optimization
Sungyeun Bae, Eunwoo Kim, Su-Jin Rhee, et al.
Drug Design, Development and Therapy
|
January 7, 2022
Comparative Pharmacokinetics/Pharmacodynamics of Fixed-Dose Combination of Esomeprazole and Calcium Carbonate (AD-206) to the Conventional Esomeprazole
Sungyeun Bae, Jihoon Kwon, Si-Beum Lee, et al.
Page
of 35
Search research articles
Search
Showing results (51-60 of 349) with videos related to
Sort By:
Page
of 35
Drug Design, Development and Therapy
|
October 23, 2014
Evaluation of the pharmacokinetic and pharmacodynamic drug interactions between cilnidipine and valsartan, in healthy volunteers
Jieon Lee, Howard Lee, Kyungho Jang, et al.
Translational and Clinical Pharmacology
|
April 15, 2021
Comparative pharmacokinetics between tenofovir disoproxil phosphate and tenofovir disoproxil fumarate in healthy subjects
Sangmi Lee, Eunwoo Kim, Seol Ju Moon, et al.
International Journal of Clinical Pharmacology and Therapeutics
|
December 22, 2018
Pharmacokinetic comparison of gemigliptin 50 mg and metformin 500 mg as a fixed-dose combination and loose combination
Sang Won Lee, Sang-In Park, SeungHwan Lee, et al.
Drug Design, Development and Therapy
|
November 22, 2017
A comparative pharmacokinetic and tolerability analysis of the novel orotic acid salt form of tenofovir disoproxil and the fumaric acid salt form in healthy subjects
Yu Kyong Kim, Mun Ju Choi, Tae Young Oh, et al.
International Journal of Clinical Pharmacology and Therapeutics
|
September 13, 2016
A bioequivalence study of two omeprazole formulations in healthy male volunteers
Yu Kyong Kim, Seonghae Yoon, Kyung-Sang Yu, et al.
Investigational New Drugs
|
January 29, 2014
An assessment of the pharmacokinetics, pharmacodynamics, and tolerability of GCPGC, a novel pegylated granulocyte colony-stimulating factor (G-CSF), in healthy subjects
Kwang-Hee Shin, Kyoung Soo Lim, Howard Lee, et al.
International Journal of Clinical Pharmacology and Therapeutics
|
April 10, 2020
Comparative pharmacokinetics of a montelukast/levocetirizine fixed-dose combination chewable tablet versus individual administration of montelukast and levocetirizine after a single oral administration in healthy Korean male subjects
Seol Ju Moon, Kyung-Sang Yu, Jina Jung, et al.
Drug Design, Development and Therapy
|
September 15, 2025
Population Pharmacokinetic and Pharmacodynamic Modeling of Enteric-Coated Aspirin Capsule and Tablet Formulations in Healthy Subjects
JaeEun Koh, Juyoung Khwarg, Kyung-Sang Yu, et al.
Journal of Clinical Pharmacology
|
April 16, 2026
Population Pharmacokinetic Analysis of MIT-001, a Novel Ferroptosis Inhibitor, for Dose Optimization
Sungyeun Bae, Eunwoo Kim, Su-Jin Rhee, et al.
Drug Design, Development and Therapy
|
January 7, 2022
Comparative Pharmacokinetics/Pharmacodynamics of Fixed-Dose Combination of Esomeprazole and Calcium Carbonate (AD-206) to the Conventional Esomeprazole
Sungyeun Bae, Jihoon Kwon, Si-Beum Lee, et al.
Page
of 35